Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort.

Authors

Stephanie Dixon

Stephanie Dixon

St Jude Children's Research Hospital, Memphis, TN

Stephanie Dixon , Lu Lu , Carmen Louise Wilson , John L. Jefferies , Thomas E. Merchant , Rebecca M. Howell , Kirsten K. Ness , Deo Kumar Srivastava , Melissa M. Hudson , Leslie L. Robison , Wassim Chemaitilly , Gregory T. Armstrong

Organizations

St Jude Children's Research Hospital, Memphis, TN, St. Jude Children's Research Hospital, Memphis, TN, The University of Tennessee Heath Science Center, Memphis, TN, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Funding

U.S. National Institutes of Health
U.S. National Institutes of Health, Athe American Lebanese-Syrian Associated Charities (ALSAC)

Background: Cardiac death among survivors of childhood cancer occurs at > 10 times the rate expected in the general population. Modifiable cardiovascular risk factors, including diabetes, increase risk for major cardiac events in a near multiplicative fashion. Thus, prevention of progression from prediabetes to diabetes could improve long-term cardiac morbidity and mortality. However, little is known about prediabetes in survivors. Methods: Prevalence of prediabetes (fasting glucose 100-125 mg/dL or HbA1c 5.7-6.4%) and diabetes were assessed in 3529 5+ year survivors ≥18 years of age and compared to 450 community controls stratified by age and matched for race/ethnicity, sex, and BMI using Chi-squared statistics. Logistic regression estimated risk factors for prediabetes and cox proportional hazards regression for progression from prediabetes to diabetes among survivors with multiple visits, reported as odds (OR) and hazard ratio (HR), respectively, with 95% confidence intervals (CI). Results: Among 3529 survivors (median age 30 years, range 18-65), the prevalence of prediabetes overall was 29.2% (95% CI 27.7-30.7) and diabetes was 6.5% (5.7-7.3). In each age strata, survivors had significantly higher prevalence of prediabetes and diabetes than controls with over 50% of middle-aged survivors (35-44 years) having prediabetes or diabetes (Table). In a multivariable model, therapy-related risk factors for prediabetes included high pancreatic tail dose (≥20 Gy: 2.9 [1.8-4.8]) and moderate prescribed cranial radiation dose (OR [95% CI] > 0- < 20 Gy: 1.4 [1.1-1.8], 20- < 30 Gy: 1.4 [1.0-1.9]) independent of age, sex, race/ethnicity and BMI. Among 695 survivors with prediabetes and longitudinal follow-up, median 5.1 years, 68 (10%) progressed to diabetes. After adjustment for age, sex, race/ethnicity and BMI, risk of progression from prediabetes to diabetes was increased by the presence of insulin resistance (HR 4.9 [95% CI 2.3-10.6]) or prior treatment with hematopoietic cell transplant (HR 2.9 [1.1-7.7]) or total body irradiation (HR 4.6 [1.6-13.5]). Conclusions: Survivors of childhood cancer have a high prevalence of prediabetes and high rates of progression to diabetes. Strategies that prevent progression to diabetes should be considered to decrease diabetes risk and subsequent cardiac morbidity and mortality in this high-risk population.

Age (years)Prediabetes
Diabetes
Survivors %Controls %Survivors %Controls %
18-2417.09.42.61.2
25-3428.114.64.82.5
35-4441.422.811.26.6
45-5446.526.416.513.2
55-6443.329.416.70.0

U.S. National Institutes of Health Athe American Lebanese-Syrian Associated Charities (ALSAC)

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Survivorship

Citation

J Clin Oncol 38: 2020 (suppl; abstr 10548)

DOI

10.1200/JCO.2020.38.15_suppl.10548

Abstract #

10548

Poster Bd #

435

Abstract Disclosures